Treatments Archives - Page 3 of 5 - Stephen's MS Journey

Tovaxin an Autologous Vaccine from Opexa Therapeutics of Houston

Tovaxin now known as Tcelna is an autologous MS vaccine developed by Opexa Therapeutics of Houston, Texas

This is an autologous vaccine, meaning the T-cells used to create the vaccine are taken from a blood sample donated by the patient.

Laquinimod in Phase III trials – BRAVO

Laquinimod is an oral medication in late stage trials showing some possible improvement in MS symptoms.

Comparison testing laquinimod against interferon beta-1a is inconclusive.

Therapeutic Chicken Eggs produce Interferon for MS

Genetically modified chickens produce complex protein-containing eggs that may be used to make drugs to treat cancers or MS.

The Roslin Institute, famous for Dolly the sheep, is leading this pioneering genetic engineering.

Interferon Beta a disease modifying treatment for RRMS

Interferon Beta is a disease modifying drug used in reducing the frequency of relapses in relapse-remitting forms of multiple sclerosis.

If you look at the list of and severity of the possible side-effects you will understand why I chose to give this treatment a wide berth.

Fingolimod An experimental MS drug from Novartis

The experimental MS drug, Fingolimod, showed a better than 50% reduction in the annual relapse rate in patients with relapsing-remitting MS.

NICE now suggests that patients who have been on beta interferon, still suffering high relapse rates, could benefit form Fingolimod.

Copaxone (Glatiramer Acetate) for MS

Glatiramer acetate or Copaxone is a disease-modifying drug administered by self subcutaneous injection.

I was offered this treatment some years past and I declined, as the possible benefits were far outweighed by the inconvenience and likely side-effects of Copaxone.

Campath (Alemtuzumab) used for Leukemia and MS

Campath is a monoclonal antibody. Used against Leukemia and is being trialled for use in Multiple Sclerosis

The interim results of a phase II trial in 2006 show promise.

Aimspro an MS Treatment derived from Goat’s Blood Serum

Aimspro is derived the serum of blood obtained from specially vaccinated goats. Aimspro has been developed to treat MS.

Produced by Daval International, details published in “New Pathways” magazine.

Named Patient Basis for Aimspro

Aimspro available on a ‘Named Patient’ basis if you have a private prescription and a lot of money.

Patients will be asked to sign a disclaimer absolving the doctor from all responsibility should something adverse happen.
For the first time, your doctor must do the injection.

Aimspro on Private Prescription

Dickson Chemists based in Glasgow, Scotland have been dispensing large numbers of Aimspro prescriptions. They have special transport containers for Aimspro.

I last investigated this product in 2006, so I have no idea if this is still relevant. As far as I can tell Daval are still marketing Aimspro.

By continuing to use the site, you agree to the use of cookies. more information

Afghanistan

Month: August 2015